Mad Money W/ Jim Cramer

The Dow soared 531 points today after renewed stimulus hopes and Jim Cramer is digging deeper into today's action. Next, after reporting, Levi Strauss & Co. CEO Chip Bergh breaks down the most recent quarter and how the company plans to move into the holiday season. Then, after a string of positive tests amongst NFL teams, BioReference Labs Executive Chairman Dr. Jon Cohen checks in to give a clearer picture of the situation. Plus, Cramer's exclusive with Exact Sciences CEO Kevin Conroy.

The Dow sank 376 points today after stimulus hopes were dimmed and Jim Cramer is diving into today's volatility. Then, Paychex CEO Marty Mucci breaks down today's earnings call and how the company's small to medium size businesses are handling the pandemic. Then, after its recent rebound, Cloudflare CEO Matthew Prince checks in with Cramer to dig deeper into how the September tech sell-off impacted the company. Plus, Cramer's exclusive with Generac CEO Aaron Jagdfeld.

The Dow jumped 466 points to kick off the week and Jim Cramer is breaking down today's top news stories and how the market reacted. Then, after the announcement of their acquisition of biotech MyoKardia, Bristol Myers CEO Dr. Giovanni Caforio checks in to take a closer look at what's in the pipeline and where the company's headed. Next, Slack CEO Stewart Butterfield talks about the work-from-home movement and how it's impacting the company. 

The Dow closed marginally higher, up 35 points, and Jim Cramer is diving into what happened on Wall Street today. Next, as Bed Bath & Beyond soars above and beyond after reporting, CEO Mark Tritton checks in to talk about a surge in online sales. Then, could Constellation Brands get a buzz after reporting better-than-expected earnings? CEO Bill Newlands breaks down the most recent quarter. Plus, Cramer's exclusive with Conagra CEO Sean Connolly.

Today, CNBC launched its newest daily podcast, The News with Shepard Smith. Each day, expect deep, non-partisan coverage and perspective on the day's most important stories. Featuring on-the-ground reporting from around the globe, The News with Shepard Smith goes beyond the headlines to give listeners sharp context into the world around them. It is punctuated by compelling, thought-provoking expert guests – all pulled together by Shepard Smith's trademark devotion to speed, accuracy and the trust of his audience. Available to listen daily by 8:30pm ET / 5:30pm PT.

The Dow jumped 329 points and Cramer is digging into today's action. Then, what’s on the horizon for Docusign? Cramer's got CEO Dan Springer to take a closer look at the stock's recent correction and what the future might look like. Next, get to know tech company Asana after its first day of trading. Plus, Salesforce.com CEO Marc Benioff stops by to talk about the private sector's impact on coronavirus aid.

The Dow fell 131 points, with all three major indices snapping a three-day winning streak, and Jim Cramer is taking a closer look into what drove today's market moves. Then, McCormick CEO Lawrence Kurzius checks in with Cramer after today's earnings to detail where the company is headed after the knock-out quarter driven by sales growth. Next, as the world continues to social distance and look for outdoor activities, Polaris, Inc. CEO Scott Wine talks about COVID-led demand for snowmobiles, all-terrain vehicles, motorcycles and more. Plus, Cramer's exclusive with Thor Industries CEO Bob Martin.

The News with Shepard Smith is CNBC's daily news podcast providing deep, non-partisan coverage and perspective on the day's most important stories. Featuring on-the-ground reporting from around the globe, The News with Shepard Smith goes beyond the headlines to give listeners sharp context into the world around them. It is punctuated by compelling, thought-provoking expert guests – all pulled together by Shepard Smith's trademark devotion to speed, accuracy and the trust of his audience. Available to listen by 8:30pm ET / 5:30pm PT daily beginning Wednesday, 9/30.

After a wild week for the averages, the Dow closed up 359 points, erasing some of the week's earlier losses, and Jim Cramer is cluing you into next week's action with his Gameplan. And, how should investors approach Palantir as it prepares to come public next week? Cramer's taking a closer look at the data-mining software company and what to do when it hits the market. Plus, Cramer’s exclusive with Brunswick CEO, David Foulkes.

The Dow closed up 50+ points and Jim Cramer is here to help investors make sense of today’s market and what could happen if there’s no more stimulus. Then, Cramer’s taking a closer look at Nvidia’s Acquisition of Arm Holdings. And, Cramer’s taking a look at a few investors portfolios to see if they’re diversified enough and playing ‘Am I Diversified’. Plus, Cramer’s talking to the CEO of Sanofi, Paul Hudson. 

The Dow closed down 525 points, swinging 680+ points, and Jim Cramer is helping investors navigate the ongoing bear market. Then, as the wave of public offerings continues, Cramer's taking a closer look at today's IPO GoodRx and how it might fit into your portfolio. Next, as the aftershocks of Nike's better-than-expected earnings continue to shake up the market, what should investors do with the stock as it hits all-time highs? Cramer's digging deeper into the call and where to go from here. Plus, Cramer's exclusive with Anaplan CEO Frank Calderoni.

The Dow snapped its losing streak, closing up 140 points, and Jim Cramer is digging deeper into today's rally. Then, what could the future of fashion and retail look like? Cramer's checking in with Macy's CEO Jeff Gennette to get a pulse of the department store as COVID-19 continues to bring down retail stocks. Next, Cramer's going Off The Charts to take a closer look at the market's potential for retesting its lows and where it could go from the past week's downturn. Plus, after returning to pre-pandemic levels, e.l.f Beauty CEO Tarang Amin discusses new brands and rallying back from its March lows.

The Dow was down 942 points at its session lows in a September-style selloff to start the week and Jim Cramer is helping investors navigate the day’s volatility. Then, as pharmaceutical companies focus on COVID-19, Eli Lilly CEO Dave Ricks checks in to discuss the company's progress with cardiology, migraine, and cancer drugs as well as a COVID-19 treatment. Then, Cramer's got the exclusive with the CEO of Coca-Cola, James Quincey, to break down demand brought on by the pandemic. Plus, Albertsons Companies CEO Vivek Sankaran joins Cramer to talk about the company’s recent IPO.

The Dow ended the week down 245 points, and Jim Cramer’s giving you his Game Plan for next week's action. Then, as Unity Software makes its market debut, Cramer's breaking down what you need to know about the newest gaming stock on the market. And, what should you make of the food delivery space? Cramer’s talking to the CEO of private-player, Slice, about food delivery and helping small businesses amidst the pandemic. Plus, after this week’s red-hot tech IPOs, Cramer's getting a read on the space with Splunk CEO, Doug Merritt.

The Dow slipped 130 points and Jim Cramer’s taking a closer look at what made the market tumble today. Then, does the move to working from home have staying power? Cramer’s revealing some signals he’s watching that have influenced his thoughts. Then, with Amwell making its public debut, what should investors make of the telemedicine play? Cramer's digging deeper into the stock. Plus, as volatility in tech continues, Proofpoint CEO Gary Steele checks in to break down the cybersecurity company's recent downturn after reiterating 3Q20 and full-year guidance.

The Dow closed marginally higher while the Nasdaq slipped into the red and Jim Cramer is helping investors break down today's headlines. Then, Campbell’s Soup CEO Mark Clouse is here to get a read on the pantry as a fall resurgence of COVID - and potentially the packaged food plays, looms. Next, as Snowflake dominated headlines, JFrog debuted under the radar today and Cramer is digging deeper into the IPO. Plus, Cramer's exclusive with Box CEO Aaron Levie.

Led by tech, the Dow and Nasdaq closed in the green and Jim Cramer is breaking down today's action. With a roaring bull market in transports, could railroad operator Union Pacific be in for more upside after its recent run? Cramer's got CEO Lance Fritz to get a better read on where the company's headed. Next, Lennar Executive Chairman Stuart Miller checks in to take a closer look into the stock's post-earnings slide. Plus, Cramer's going Off The Charts to dig deeper into stocks like Caterpillar, Dr. Horton and RH as they continue to rally.

The Dow started the week, closing up 328 points and Jim Cramer's breaking down today's headlines and getting investors ready for the trading week ahead. Then, as the long-awaited IPO Snowflake comes public this week, Cramer is taking a closer look at the company and making sense of what to do with the stock. Then, GW Pharmaceuticals CEO Justin Gover checks in to break down the company's most recent quarter. Plus, how could vaccine hopes be impacting the market each day? Cramer's breaking down all the stocks that are moving the most on headlines for a COVID treatment.

Stocks closed mostly mixed after a volatile week of trading and Jim Cramer is giving you his Game Plan for what to look out for next week. Then, as a wave of IPOs hit the market, Cramer is breaking down a few of the companies that are coming public in the week ahead. Plus, as Nikola continues to make headlines, Cramer is digging deeper into the stock's rocky debut after its recent IPO.

All three major indices closed in the red for the 4th out of 5 days, with the Dow swinging 700+ points and Jim Cramer is helping investors manage their own money through volatile trading days like today. Next, after an explosive debut and better-than-expected earnings, how should investors approach recent IPO nCino? CEO Pierre Naudé digs into the company's quarter and where the young company is headed. Then, RH CEO Gary Friedman breaks down the impact that quarantine and stay-at-home orders have had in driving growth. Plus, Cramer's exclusive with Sage Therapeutics CEO Jeff Jonas.